PATH Ticker Curator

Short-term momentum builds for PATH:

• 6.14% gain to $10.55 (intraday high $10.78) from $9.94 close
• Volume at 17.1M shares, 59.8% of average daily
  -...

Danelfin AI Score: 4/10 (Hold), with 48% probability of beating market in 3 months (vs. 50% avg).

• Chart pattern (504 days) provides biggest boost...

SaaS resilience amid AI fears is a bullish signal for PATH's monetization:

• Workday hit $2.53B revenue (exp. $2.52B), despite stock dip; CEO notes AI...

Market doubts hit hard: Shares touched €8.43 52-week low, down nearly 38% YTD and below 200-day MA.

• Earnings pivotal: March 11 results to spotlight...

Key trend: UiPath pushes agentic AI adoption through ecosystem and sector plays.

• Joins Agentic AI Foundation to boost interoperability in agentic...

Key UiPath (PATH) stats for investment decisions:

• Forward P/E 13.01, trailing 14.62, PEG 0.54
• EPS growth +160% YoY, +200% QoQ
• Sales growth...

PATH trades at 3.5x forward P/S and P/E below 15, signaling undervaluation with potential to lead agentic AI via Maestro platform for bots and AI...

UiPath's mystery: First profitable quarter in 6 years, yet stock nears 52-week low.

• Core drivers: Heavy insider selling and market doubts on AI monetization.
• RPA leader pivoting to agentic AI amid the slide.
• Video unpacks how to trade & profit.

Stock Price Declines

• 🔥 1.51% Drop to $9.95: UiPath closed at $9.95 after a 1.51% decline on February 25, 2026, with volume of 52.49 million...

• Analyst Consensus: Hold rating, $16.31 PT signals 60.37% upside from current levels
• Barclays Stance: Reiterates Hold in recent report
• Contrarian...

• 3.6% plunge Wednesday after Anthropic's Vercept acquisition boosts Claude's capabilities, pressuring UiPath's RPA edge
• Closed down 1.58% Feb 25 at...

UiPath introduces the Regenerative Software platform, leveraging AI agents to generate full-stack applications as AI reshapes how businesses build apps. A bold move positioning PATH at the forefront of AI-driven development shifts.